169 related articles for article (PubMed ID: 21245444)
1. Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine.
Dalhoff A; Stubbings W; Schubert S
Antimicrob Agents Chemother; 2011 Apr; 55(4):1814-8. PubMed ID: 21245444
[TBL] [Abstract][Full Text] [Related]
2. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth.
Hackel MA; Tsuji M; Yamano Y; Echols R; Karlowsky JA; Sahm DF
Diagn Microbiol Infect Dis; 2019 Aug; 94(4):321-325. PubMed ID: 31029489
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
Gismondo MR; Chisari G; Lo Bue AM
Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of difloxacin against canine bacterial isolates.
van den Hoven R; Wagenaar JA; Walker RD
J Vet Diagn Invest; 2000 May; 12(3):218-23. PubMed ID: 10826834
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of LY146032 against gram-positive bacteria.
Silva M; Jacobus NV; Gorbach SL
Diagn Microbiol Infect Dis; 1988 Feb; 9(2):79-85. PubMed ID: 2838217
[TBL] [Abstract][Full Text] [Related]
7. [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Noviello S; Ianniello F; Leone S; Esposito S
Infez Med; 2006 Mar; 14(1):24-8. PubMed ID: 17405239
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
Chau PY; Leung YK; Ng WW
Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
[TBL] [Abstract][Full Text] [Related]
9. Comparative activities of clinafloxacin against gram-positive and -negative bacteria.
Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 May; 42(5):1269-73. PubMed ID: 9593165
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cation-adjusted Mueller-Hinton broth with Iso-Sensitest broth for the NCCLS broth microdilution method.
Koeth LM; King A; Knight H; May J; Miller LA; Phillips I; Poupard JA
J Antimicrob Chemother; 2000 Sep; 46(3):369-76. PubMed ID: 10980162
[TBL] [Abstract][Full Text] [Related]
12. [In vitro comparison of ciprofloxacin with other antibiotics against multiresistant gram-negative bacilli].
Soto Hernández JL; Angeles Morales V; Perea Mejía B; Hernández Velázquez M; Martínez Zubieta R; Pasquel Rivera C
Rev Invest Clin; 1991; 43(4):318-22. PubMed ID: 1798865
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
Wang S; Jia XD; Liu ML; Lu Y; Guo HY
Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial.
Gootz TD; Brighty KE; Anderson MR; Schmieder BJ; Haskell SL; Sutcliffe JA; Castaldi MJ; McGuirk PR
Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system.
Roveta S; Marchese A; Debbia EA
J Chemother; 2006 Feb; 18(1):12-9. PubMed ID: 16572888
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the results of determining antibiotic sensitivity on AGV medium and on Mueller-Hinton and isosensitest agars].
Kozlov RS; Strachunskiĭ LS; Livermor DM; Stetsiuk OU; Shavrikova EP
Antibiot Khimioter; 1996; 41(10):22-7. PubMed ID: 9027288
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
Bauernfeind A; Jungwirth R; Schweighart S
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
[TBL] [Abstract][Full Text] [Related]
19. In-vitro selection of bacteria resistant to the 4-quinolone agents.
Limb DI; Dabbs DJ; Spencer RC
J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
